Le Lézard
Classified in: Health
Subjects: TDS, WOM, FVT

Leading Expert And Rector Of Oslo And Akershus University College Of Applied Sciences, Curt Rice, Is Set To Discuss The Science Of Unconsious Bias At The Joint Annual Meeting ISMRM-ESMRMB in Paris, 16 - 21 June 2018


CONCORD, California, May 24, 2018 /PRNewswire/ -- The International Society for Magnetic Resonance in Medicine (ISMRM) and the European Society of Magnetic Resonance in Medicine and Biology (ESMRMB) invite attendees at their joint annual meeting (www.ismrm.org) to attend the Presidential Lecture on 20 June featuring the leading expert on gender equality and unconscious bias, Curt Rice, Ph.D.  The lecture is entitled "When the Right Thing to Do Is Also the Smart Thing to Do: Research & Results on Diversity in Research Organizations."

ISMRM (International Society For Magnetic Resonance In Medicine)

Rice is having the academic world rethink topics such as leadership development and gender balance as a tool to enhance and increase quality and performance as it applies to scientific results and research-based education.  He leads Norway's Committee for Gender Balance and Diversity in Research and is heavily involved in many other leading organizations. 

In a riveting post, Rice stated, "Gender equality has not yet been achieved in the workplaces of the western world. Research institutions have a special responsibility to contribute to progress. Knowledge gives insight as we identify the challenges that remain; our job is to deliver that knowledge.  How will we know that gender equality has been achieved? One hallmark of true gender equality is that the sex of an employee does not affect processes such as hiring, evaluation, setting salaries, and other processes in the workplace."

ISMRM president Daniel K. Sodickson, M.D., Ph.D., says, "It is one of our Society's core values to connect diverse constituencies -- for example, clinicians and basic scientists from countries around the world -- and at this we truly excel.  Nevertheless, we still have a long way to go in leveraging, and reflecting, the true diversity of our membership.  To cite just one concrete example: of the 80 Gold Medals the ISMRM has conferred, only 4 have gone to women, though we know that women have played an essential role in the ongoing development of our field.  For our inaugural President's Lecture at our Annual Meeting this year in Paris, we have sought out a true international leader to present to our evidence-based community with some of the emerging evidence about diversity, inclusion, and unconscious bias in scientific communities like ours.  Curt Rice is just such a leader.  The president of Oslo Metropolitan University and head of Norway's Committee on Gender Balance and Diversity in Research, Curt was recently invited by the Nobel Foundation to address the members of all the Nobel Committees regarding the challenges they face in moving towards better gender balance in the awarding of the Nobel Prizes.  In a year marked by long-overdue upheavals in the global conversation about gender and diversity, we hope that attendees of our meeting will take full advantage of this opportunity to look inward, and forward, together."

The joint ISMRM-ESMRMB annual meeting with be held at the Paris Expo Porte de Versailles, in Paris, France. The meeting opens 16 June and will welcome over 6,000 attendees specializing in the field of magnetic resonance.  If you are interested in attending, register today.  You don't want to miss this informative meeting in this dream location.

About ISMRM:

The International Society for Magnetic Resonance in Medicine is an international, nonprofit, scientific association whose purpose is to promote communication, research, development, and applications in the field of magnetic resonance in medicine and biology and other related topics and to develop and provide channels and facilities for continuing education in the field. Its multidisciplinary membership of over 9,000 consists of clinicians, physicists, engineers, biochemists, and technologists. In addition to its large scientific meetings, the Society holds workshops and publishes two journals, Magnetic Resonance in Medicine and the Journal of Magnetic Resonance Imaging, and a virtual newsletter, MR Pulse. It also sponsors 27 study groups on specific areas of scientific interest and chapters based on geographical location.

To find out more about the International Society for Magnetic Resonance in Medicine (ISMRM), please call +1 510-841-1899, Fax +1 510-841-2340, or visit our website at www.ismrm.org.

ISMRM, One Concord Center, 2300 Clayton Road, Suite 620, Concord, CA 94520 USA

Contact: Parshy Phillips, ISMRM
Phone: 510-841-1899
Email: [email protected]

Logo - https://mma.prnewswire.com/media/695901/ISMRM_Logo.jpg


These press releases may also interest you

at 04:28
GymNation, the homegrown UAE fitness brand, has today announced that due to unprecedented growth, it is reaching capacity across its 12 UAE gym locations and diversifying into a new market, brewing up a storm with the launch of its first-ever branded...

at 04:00
Cancer spreads from its primary tumor to other parts of the body via blood or the lymphatic system in a process termed 'metastasis'. This usually represents an advanced stage in the disease's progression and tends to be fatal. Therefore, preventing...

at 03:30
Vicore Pharma Holding (STO:VICO)Sessions at ATS to include an oral late-breaking presentation of the final results from the Phase 2a AIR trial of buloxibutid (C21) in IPFAdditional presentations include preclinical and translational data reflecting...

at 03:13
Orexo's Annual and Sustainability Report for 2023 has been published and can be downloaded at, www.orexo.com. The Swedish version of the Report is also available on the company's website in European Single Electronic Format (ESEF). A PDF version is...

at 03:05
Surge has just closed its second round of funding, raising ?7.5 million. The round was led by Eurazeo with the participation of Kima, Teampact, and MH Innov', as well as the support of historical funds Boutique Venture, HCVC, and 50 Partners Santé....

at 03:00
CSL Vifor is pleased that its partner Akebia Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Vafseo (vadadustat) tablets for the treatment of anemia due to chronic kidney disease (CKD) in adults who...



News published on and distributed by: